JScottOvercashMDFACEP
Emergency Medicine • La Mesa, CAEmergency Physician, Principal Investigator, Medical Director
Dr. Overcash is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
5555 Grossmont Center Dr
La Mesa, CA 91942Phone+1 619-740-4401Fax+1 619-740-3972
Summary
- Dr. J. Scott Overcash is an Emergency Medicine and Clinical Research physician in San Diego, CA.
He is affiliated with Sharp Healthcare and Velocity Clinical Research. He received his medical degree from University of North Carolina at Chapel Hill School of Medicine and has been in practice 16 years.
Education & Training
University of North Carolina HospitalsResidency, Emergency Medicine, 2001 - 2004
University of North Carolina at Chapel Hill School of MedicineClass of 2001
Certifications & Licensure
CA State Medical License 2008 - 2025
NC State Medical License 2001 - 2025
FL State Medical License 2004 - 2012
HI State Medical License 2003 - 2003- American Board of Emergency Medicine Emergency Medicine
Publications & Presentations
PubMed
- 36 citationsCeftobiprole Compared With Vancomycin Plus Aztreonam in the Treatment of Acute Bacterial Skin and Skin Structure Infections: Results of a Phase 3, Randomized, Double-b...J Scott Overcash, Charles Kim, Richard Keech, Illia Gumenchuk, Borislav Ninov
Clinical Infectious Diseases. 2021-10-05 - 5 citationsEfficacy and safety of ceftobiprole in patients aged 65 years or older: a post hoc analysis of three Phase III studies.Tobias Welte, Thomas Scheeren, J Scott Overcash, Mikael Saulay, Marc Engelhardt
Future Microbiology. 2021-05-07 - 22 citationsAfabicin, a First-in-Class Antistaphylococcal Antibiotic, in the Treatment of Acute Bacterial Skin and Skin Structure Infections: Clinical Noninferiority to Vancomycin...Frederick Wittke, Catherine Vincent, James K. Chen, Barry Heller, Heidi Kabler
Antimicrobial Agents and Chemotherapy. 2020-09-21
Journal Articles
- Single-Dose Oritavancin in the Treatment of Acute Bacterial Skin InfectionsG. Ralph Corey, M.D., Heidi Kabler, M.D., Purvi Mehra, M.D., Sandeep Gupta, M.D., J. Scott Overcash, M.D., Ashwin Porwal, M.D., Philip Giordano, M.D., Christopher Luca..., The New England Journal of Medicine, 6/5/2014
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
